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ABSTRACT
Histone proteins are synthesized in large amounts
during S-phase to package the newly replicated DNA,
and are among the most stable proteins in the cell.
The replication-dependent (RD)-histone mRNAs ex-
pressed during S-phase end in a conserved stem-
loop rather than a polyA tail. In addition, there are
replication-independent (RI)-histone genes that en-
code histone variants as polyadenylated mRNAs.
Most variants have specific functions in chromatin,
but H3.3 also serves as a replacement histone for
damaged histones in long-lived terminally differen-
tiated cells. There are no reported replacement hi-
stone genes for histones H2A, H2B or H4. We re-
port that a subset of RD-histone genes are expressed
in terminally differentiated tissues as polyadenylated
mRNAs, likely serving as replacement histone genes
in long-lived non-dividing cells. Expression of two
genes, HIST2H2AA3 and HIST1H2BC, is conserved
in mammals. They are expressed as polyadenylated
mRNAs in fibroblasts differentiated in vitro, but not
in serum starved fibroblasts, suggesting that their
expression is part of the terminal differentiation pro-
gram. There are two histone H4 genes and an H3 gene
that encode mRNAs that are polyadenylated and ex-
pressed at 5- to 10-fold lower levels than the mRNAs
from H2A and H2B genes, which may be replacement
genes for the H3.1 and H4 proteins.
INTRODUCTION
The bulk of the histone proteins are synthesized coordi-
nately with DNA during S-phase and are very stable after
incorporation into chromatin. These proteins are encoded
by replication-dependent (RD)-histone mRNAs which are
the only known cellular eukaryotic mRNAs that do not end
in a polyA tail but end instead in a conserved stem-loop.
The protein that binds the stem-loop, SLBP, is required for
processing of the RD-histone pre-mRNAs and also func-
tions during the entire histone mRNA life cycle including
transport from the nucleus, translation and mRNA degra-
dation (1). Canonical RD-histone processing occurs by en-
donucleolytic cleavage following SLBP binding to the stem-
loop (2). This cleavage is directed by the U7 snRNP (3–5)
that interacts with a second histone specific sequence called
the histone downstream element (HDE) (6). These histone
mRNAs are expressed at high levels during S-phase increas-
ing 35-fold as cells enter S-phase and decreasing rapidly at
the end of S-phase (7). SLBP levels are also cell cycle regu-
lated and the increased levels of SLBP as cells enter S-phase
allows increased processing of histone mRNA. The degra-
dation of SLBP at the end of S-phase prevents further ac-
cumulation of histone mRNAs or protein (8,9).
Most studies of histone mRNAs have focused on their
expression and regulation in growing cells. An unresolved
question is how histone proteins are synthesized after cells
have terminally differentiated and no longer re-enter S-
phase. This is a particularly pertinent question for long-
lived cells. In dividing cultured cells, histones are stable with
<5% turnover of labelled histones over 8 generations (10).
The half-life of histone protein in chicken brain tissue has
been estimated at 19 days (11). In a recent proteomics study,
histones were identified as among the most stable proteins
*To whom correspondence should be addressed. Tel: +1 919 962 2140; Fax: +1 919 962 1273; Email: marzluff@med.unc.edu
Present address: ShawnM. Lyons, Department of Medicine, Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s
Hospital, Boston, MA 02115, USA.
C© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which
permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com
Nucleic Acids Research, 2016, Vol. 44, No. 19 9191
in mammalian cells (12), with histone H3.1 and H4 signif-
icantly more stable than histones H2A and H2B. Histone
turnover likely occurs as a result of damage to existing hi-
stone proteins. However, many mammalian cells have life
spans substantially longer than even the slowly turning over
histone proteins (13). How, then, do non-dividing cells such
as these maintain proper levels of histone proteins that are
critical for genome stability and the regulation of gene ex-
pression?
One possibility is that there are distinct genes that are ex-
pressed constitutively and encoded by polyadenylated mR-
NAs. The histone H3F3 genes found in all multicellular
organisms encode the variant histone H3.3, which is syn-
thesized constitutively, and plays an important role in gene
regulation. It also serves as a replacement histone H3 vari-
ant. In mice, histone H3.3 becomes the predominant his-
tone H3 protein in non-dividing cells over the lifespan of
the mouse (14). Similar to H3.3, histone H1O is encoded by
a polyadenylated RNA and the amount of H1O protein in-
creases after terminal differentiation (15). There are several
variants of histone H2A (e.g. H2A.Z, macroH2A), which
are expressed from polyadenylated mRNAs, but these have
specific functions, and likely do not serve as ‘replacement’
variants. For example, the histone H2A.X protein is ex-
pressed from a single gene and is involved primarily inDNA
repair (16). In S-phase cells, the H2A.X mRNA ends in a
stem-loop and is cell cycle regulated. Outside of S-phase
the same gene expresses a longer polyadenylated mRNA
(17,18). There are no reports of variant histone H2B genes
or histone H4 genes that express only polyadenylated mR-
NAs (e.g. like H1O or H3.3).
Some polyadenylated core histone mRNAs are produced
in small amounts in cultured cells as a result of knockdown
of a number of factors (NELF (19), ARS2 (20), chromatin
modifiers (21), P-TEFb (21), Y-RNAs (22) and SLBP (23)).
These treatments likely result in a perturbation of canon-
ical histone pre-mRNA processing after the stem-loop. In
addition, Kari et al. have shown that there is production
of some polyadenylated and spliced histone H2B mRNAs
when human fibroblasts are differentiated into adipocytes in
vitro (24). In some of these studies, the relative proportion
of polyadenylated mRNAs and properly processed mR-
NAs were determined and the amount of polyA+ RNA
was very small (<5%) (19,22). In other studies, only in-
creases in polyadenylated histone mRNAs over the very
small amounts of polyadenylated histone mRNAs present
in control cells was described (21).
Here, we show that in terminally differentiated tissues,
a subset of histone genes in the two RD-histone mRNA
clusters remain active and encode polyadenylated mRNAs.
These include one histone H1 gene, H1C, previously shown
to be expressed in many adult mouse tissues (25), as well as
genes for the four core histone proteins. All these mRNAs
are polyadenylated and, in most cases, the polyA signal is
3′ of the stem-loop and extends the 3′ UTR of the histone
mRNA. One or more histone H2B mRNAs (depending on
the species) from the HIST1 cluster are formed by splic-
ing around the histone stem-loop, resulting in a polyadeny-
lated histone mRNA lacking the stem-loop. These mRNAs
likely encode the ‘replacement’ H2A, H2B and H4 proteins
in non-dividing cells. Surprisingly, terminally differentiated
cells also express a number of genes thought to be required
only for RD-histone gene expression, including most of the
genes required for processing histone mRNA.
MATERIALS AND METHODS
RNA extraction from mouse tissue
Post-natal day 1 (P1 mice) and dissected mouse liver and
brain were quick-frozen with liquid nitrogen and stored
80◦C until use. Sections of tissue (100–200 mg) were
weighed and placed in a ceramic mortar filled will liquid
nitrogen and ground by hand. The resulting tissue powder
was transferred to a 15-ml tube and 1 ml of Trizol (Invitro-
gen) was added per 50mg of tissue, and processed as recom-
mended by the manufacturer. The RNA pellet was air dried
and resuspended in 300 l of 0.3 M sodium acetate (pH
5.6), extracted with phenol/chloroform and ethanol precip-
itated.
Preparation of protein lysate from mouse tissues
The tissue powder was prepared as described above and was
resuspended in 1 ml of NP-40 lysis buffer (150 mM NaCl,
50 mM Tris [pH 8.0], 0.5% NP-40) per 100 mg of tissue, ro-
tated at 4◦C for 20 min, and the cell lysates clarified by cen-
trifugation at 16 000 xg. The supernatant was transferred to
new tubes and the protein concentration was determined by
Bradford Assay.
S1 Nuclease protection assays
The S1 nuclease assays were performed as previously de-
scribed (26), using either total cell RNA or RNA fraction-
ated on oligo(dT) cellulose into polyA+ and polyA− frac-
tions. Each gene was cloned into pUC19 and 5 g of each
plasmid digested at restriction site in the ORF resulting
in the generation of a 5′ overhang that can be labelled by
incorporation of -[32P]-dCTP (3000 Ci/mmol) using the
Klenow fragment of DNA pol I. After labelling the plasmid
was then digested with a 2nd restriction site downstream of
the 3′ end. Description of restriction site usage and probe
size is found in Supplementary Table S1. After hybridiza-
tion and digestion with S1 nuclease as described previously,
the protected fragmentswere analysed by electrophoresis on
a 6% polyacrylamide gel containing 8M urea followed by
autoradiography.
3T3-L1 differentiation
3T3-L1 pre-adipocytes were cultured in DMEM supple-
mented with 1X penicillin-streptomycin solution (Corning)
and 10% (v/v) fetal calf serum and differentiated with mod-
ifications to protocol described previously (27). To induce
differentiation, 2-day post confluent pre-adipocytes (day 0)
were treated with an inductionmedia containing 1mMdex-
amethasone, 0.5 mM isobutylmethylxanthine and 5 g/ml
insulin (all from Sigma) in 10% fetal bovine serum (FBS)
supplemented DMEM. Two days later, induction media
was replaced with 5 g/ml insulin only until fully differ-
entiated (day 12) with media changed every 2 days. Differ-
entiation was confirmed by OilRed O stain and qRT-PCR
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quantification of pre-adipocyte and adipocyte marker gene
expression (28).
Northern blotting for U7 snRNA
U7 snRNAwas detected byNorthern blotting as previously
described using 5′ end labelled antisense oligonucleotides
and 25 g of total cell RNA (29). As an internal control
the gel was stained prior to blotting and the intensity of 5S
rRNA staining determined.
Biotinylated RNA pulldown
Cell lysates were diluted to 1 mg/ml protein in NP-40 lysis
buffer (150 mM NaCl, 50 mM Tris [pH 8.0], 0.5% NP-40)
and final concentration of EDTA was brought to 20 mM.
For each experiment, 100l lysate was incubated with 10l
of 10 M biotinylated 30 nt stem-loop RNA (Dharmacon)
for 1 h as previously described (30). The biotinylated RNA
was recovered by binding to streptavidin-agarose beads fol-
lowed by centrifugation. The unbound protein was saved
for Western blot analysis. Beads were washed 4 times with
1 ml of NP-40 lysis buffer. Bound proteins were recovered
in 25 l of SDS loading buffer and resolved on an 8% SDS-
PAGE gel for Western blot analysis.
Analysis of RNA-seq data
Reads from Illumina Human BodyMap Project were
aligned to hg19 using MapSplice2 with default settings.
UCSC gene annotations were downloaded and used to cre-
ate transcriptome annotations for RSEM. We manually
scanned the histone gene cluster to identify any genes ex-
pressed in the tissues, and confirmed that there were reads
that included the stem-loop and downstream sequences,
as well as junction spanning reads that defined the splice
sites for all 10 histone genes in each of the human samples.
We computed gene expression levels for UCSC genes using
RSEM with the settings –estimate-rspd and –paired-end.
RSEM aligns reads to a reference transcriptome in a way
designed to find all possible genes that each read could have
originated from and then uses a Bayesian network model
to estimate the abundance of all genes simultaneously. This
strategy is ideal for dealing with genes that may have many
multimapped reads, as is the case with histone genes. For
duplicated genes, RSEM computes a separate expression
level for each annotated locus. The expression levels that
RSEM reports are in units of FPKM (fragments per kilo-
base per million reads). Data from the cow and mouse tis-
sues were provided by Jason Merkin and Chris Burge (31).
RESULTS
Histone genes express polyadenylated mRNAs in human tis-
sues
There are twomajor histone gene clusters in mammals (32).
The large HIST1 cluster contains more than 50 genes, in-
cluding all of the RD-H1 proteins and the H2A.1, H2B.1
and H2B.2, H3.1 and H4 isoforms of core histone genes.
The smaller cluster, HIST2, contains about 10 genes for
core histones, including a central pair of duplicated histone
H2A and H3 genes that encode the H2A.2 and H3.2 pro-
tein variants, and depending on the species, at least one H4
gene and 2–3 other H2A and H2B genes. The structure and
gene order in both clusters is conserved in mammals, al-
though there are examples of small differences due to cre-
ation of pseudogenes and differing extents of the duplica-
tion of the central gene pair in HIST2 in some species. In
addition, there are three histone genes in the small HIST3
cluster, which are not expressed in somatic cells and a lone
H4 gene, HIST4H4, expressed coordinately with the genes
in HIST1 and HIST2, all of which have been conserved in
mammals. All of these histone genes encode mRNAs that
end in the stem-loop. Here, we analysed expression of his-
tone mRNAs in human tissues and in tissues of two other
mammals, mouse and cow, with sequencing data provided
by Jason Merkin and Chris Burge (31).
The non-polyadenylated histone mRNAs are typically
not present in the RNAs sequenced in high throughput se-
quencing projects as part of the analysis of gene expres-
sion. However, Illumina provided human sequences derived
from total cell RNA (ribominus) from 15 adult tissues. The
mouse and cow sequences were all polyA+ mRNA from
terminally differentiated tissues. We also analysed expres-
sion of histone genes in human breast tumour tissue (both
ribominus and polyA+) and normal adjacent breast tissue
(poly A+) from the TCGA project at UNC.
The histone mRNA expression pattern was similar in
all 15 human tissues in the Illumina data set. There was
essentially no histone mRNA expressed in tissues from
most histone genes, as expected, since most of the tissues
consisted largely of non-dividing cells. The ‘replication-
independent’ histone genes, H3.3, H2A.Z, the polyadeny-
lated formof histoneH2A.X, histoneH1O, andmacroH2A,
were expressed in all the tissues (Supplementary Fig-
ure S1). We were surprised there was expression of the
same subset of RD-histone genes in all 15 terminally
differentiated human tissues as polyadenylated mRNAs
(Table 1). The ten expressed histone mRNAs were the
HIST1H2AC, HIST1H2BC (Figure 1A), HIST2H2AA3
(Figure 1B), HIST1H1C (Figure 1 C), HIST1H4H (Fig-
ure 1D), HIST1H2BD (Figure 1E) and HIST1H2BK (Fig-
ure 1F), HIST1H3E (Figure 1H), HIST2H4 (Figure 1J)
andHIST1H2BE (data not shown). Of these, HIST1H2BC,
HIST1H2AC, HIST1H2BD, HIST1H2BK, HIST1H4H
and HIST2H4 were expressed as spliced and polyadeny-
lated mRNAs (Table 1). The HIST1H1C, HIST1H3E,
HIST1H2BE gene and the duplicated HIST2H2AA3 genes
were expressed as mRNAs that were polyadenylated, but
not spliced. Screenshots of the expression of these genes are
shown in Figure 1, together with examples of genes adja-
cent to HIST2H2AA3 (Figure 1B), HIST1H2BD (Figure
1E) and HIST1H2BK (Figure 1F) that were not expressed.
In each case, there were multiple sequence reads extending
through the stem-loop into the adjacentDNA, and they ter-
minated following a polyadenylation signal downstream of
histone stem-loop (Figure 1A–F, lower panels). This is in
contrast to the polyA− histone RNAs expressed in HeLa
cells (33,34) where the reads terminated before the stem-
loop (the random primer used to prepare cDNA is not able
to prime cDNA within the stem-loop).
Nucleic Acids Research, 2016, Vol. 44, No. 19 9193
Figure 1. A subset of replication-dependent histone mRNAs are expressed in terminally differentiated tissues. (A–F) Sashimi plots RNA-Seq (ribominus)
of total RNA from human tissues in the Illumina BodyMap project showing expression of the indicated histone genes in brain (Red) and liver (Blue) for (A)
HIST1H2AC and HIST1H2BC; (B) HIST2H3C (not expressed) and HIST2H2AA3; (C) HIST1H3C (not expressed) and Hist1H1C; (D) HIST1H4H; (E)
HIST1H1E (not expressed) and Hist1H2BD; (F) Hist1H4I (not expressed), Hist1H2BK and Hist1H2AH (not expressed). Note that there is no expression
of adjacent histone genes. Sequences below sashimi plots indicate important sequence motifs; stem-loops(underlined), 5′ splice sites (green) and polyadeny-
lation signals (red). (G) Sequence comparison of HIST1H2B genes whose mRNAs are spliced and polyadenylated. Conserved 5′ splice site (green) and
stem-loop (underlined) are indicated. Note that the location of the 5′ splice site results in removal of the stem-loop from the polyadenylated mRNA. (H–J)
Sashimi plots of normal human breast tissue from a representative TCGA sample for (H) HIST1H3E, (I) HIST1H4H and (J) HIST2H4.
Table 1. Polyadenylated Human histone mRNAs and their mouse orthologs
Human Gene Is the mRNA spliced?
Does the mature
mRNA retain its
stem-loop? FPKM Mouse Ortholog
Is the mouse ortholog
PolyA+?
Hist1H1C No Yes 14.9 ± 3.6 Hist1H1c Yes
Hist1H2AC Yes Yes 21.1 ± 5.5 Hist1H2ac No
Hist2H2AA3 No Yes 9.2 ± 3.2 Hist2H2aa1 Yes
Hist1H2BC Yes No 1.0 ± 0.5 Hist1H2bc Yes
Hist1H2BD Yes No 8.6 ± 2.7 Pseudogene N.A.
Hist1H2BK Yes No 29.5 ± 4.7 Hist1H2bk No
Hist2H2BE No Yes 10.9 ± 3.7 Hist2H2be N.D.
Hist1H3E No Yes 1.1 ± 0.3 Hist1H3e N.D.
Hist1H4H Yes Yes 1.3 ± 0.2 Hist1H4h N.D.
Hist2H4 Yes Yes 2.9 ± 0.9 Hist2H4 Yes
For each human gene, table indicates whether or not mature polyA mRNA is spliced or whether the histone stem-loop is retained in the mature polyA
mRNA.Mouse orthologs of human genes that produce polyadenylatedmRNAswere identified and analyzed as to whether or not they produce polyadeny-
lated mRNAs. *Two isoforms present in Human Hist1H2AC. FPKM ± Standard Deviation. N.D.= Not detected, N.A. = Not applicable.
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TheHIST1H2AC,HIST1H4HandHIST2H4 geneswere
expressed as polyadenylated mRNAs that were spliced af-
ter the normal 3′ end of the histone mRNA. Note the
green highlighted sequence indicating the 5′ splice donor.
This processing reaction results in mature mRNA that
contains both a stem-loop and a polyA tail, similar to
the structure of the polyadenylated histone mRNAs that
were not spliced. The HIST1H2AC gene shares a promoter
with the adjacent HIST1H2BC, which is also expressed
as a spliced and polyadenylated mRNA (Figure 1A), al-
beit at lower levels than HIST1H2AC. Two other H2B
genes, HIST1H2BD and HIST1H2BK, are also expressed
as spliced and polyadenylated mRNAs (Figure 1E–F). The
HIST1H2BK gene was adjacent to the HIST1H2AH gene
and the HIST1H2BDwas adjacent to the HIST1H1E gene,
neither of which was expressed (Figure 1E–F). In contrast
to HIST1H2AC, the spliced and polyadenylated H2B genes
produced mature mRNAs that lacked the stem-loop, be-
cause the 5′ splice donor site is located between the stop
codon and stem-loop (Figure 1G, green highlighted se-
quence). Note that the H2B mRNAs will not be targets for
nonsense-mediated decay (NMD). Efficient NMD requires
that the stop codon be >55 nts from the exon-junction and
that the efficiency of NMD increases only as the distance
between the stop codon and multiple exon junctions in-
crease (35,36). The distance between the stop codon and
5′ splice site is >55 nts for HIST1H4H (Figure 1D) and
Hist2H4 and this may contribute to the low levels of ex-
pression of these genes among the spliced histone mRNAs
(Table 1, c.f. HIST1H4H and HIST1H2AC, HIST1H2BC,
HIST1H2BK, HIST1H2BD).
To further confirm the expression of these genes in nor-
mal human tissue, we analysed sequencing data from the
TCGAproject at UNC-Chapel Hill, where adjacent normal
breast tissue as well as breast tumour tissue was sequenced,
and where the sequencing was done to a deeper depth. The
data from normal tissue confirmed the results from the data
obtained from Illumina, and similar levels of expression
of the polyadenylated histone mRNAs were found in each
sample (Table 1). In this data set, we identified a single hi-
stone H3 gene, HIST1H3E, which was expressed at a simi-
lar level as the HIST1H4H gene (Figure 1H), each with an
FPKM of about 1, compared to the level of 10–30 FPKM
found for the H2A, H2B andHIST1H1C genes. Analysis of
this data set also demonstrated sequencing reads that span
splice junctions for the two expressedH4 genes, HIST1H4H
andHIST2H4 (Figure 1I and J). The histoneH2A andH2B
mRNAs were expressed at a significantly higher level than
the histoneH4 orH3mRNAs. TheH3/H4protein tetramer
is much more stable than the H2A/H2B protein dimer (12);
therefore, it is likely that it does not require as high expres-
sion to maintain proper levels within chromatin. In total,
10 of the 65 histone genes in the HIST1 and HIST2 clusters
were expressed in tissues as polyadenylated mRNAs (Table
1).
Similar sets of histone mRNAs are expressed in tissues of
other mammals
We examined the expression of histone genes from the tis-
sues of two other mammals, mouse and cow, using sequenc-
ing data obtained from Jason Merkin and Chris Burge (31)
(GSE41637). These data contained only sequences from
polyadenylated mRNAs, but were sufficient for us to iden-
tify the replication-dependent histonemRNAs that were ex-
pressed as polyadenylated mRNAs in these non-dividing
tissues (Figure 2). Since the mouse core histone genes are
over 95% conserved at the nucleotide level (37,38), it was
not possible to unambiguously map reads containing only
coding region sequences to individual genes. However, the
polyadenylated mRNAs could be mapped because of the
unique sequences in the 3′ UTR before and after the stem-
loop. Like the human histone genes, the cow histone genes
have enough differences in the coding regions to assign se-
quencing reads to individual histone genes. Although the
histone gene cluster was not completely annotated in the
cow genome, we determined that its organization was the
same as the mouse and human cluster and identified the or-
thologues of each of the genes expressed in humans. Note
that the naming convention for all human genes has the hu-
man genes capitalized (e.g. HIST1H2BC) and the ortholo-
gous genes in other mammals (i.e. mouse and cow) genes in
lower case (e.g. Hist1H2bc) (32).
The orthologues of the HIST1H2BC (Figure 2A),
HIST2H2AA3 (Figure 2B) and HIST1H1C (Figure 2C)
genes were expressed in both cow andmouse brain (data not
shown) and liver (Figure 2). The Hist1H2bd gene was also
expressed in cow, but not in mouse where it is a pseudogene
(32). The HIST1H2BK gene is the most highly expressed
H2B gene in human tissues (Table 1), but it’s orthologue,
Hist1H2bk, is not expressed in mouse or cow tissues as the
5′ splice site in the Hist1H2bk gene is less well conserved
throughout evolution and is not conserved in mouse or cow
(Supplementary Figure S2). As in humans, the Hist1H2bc
gene is found in a gene pair with Hist1H2ac in mouse and
cow. In humans, both mRNAs are spliced and polyadeny-
lated, but expression of the Hist1H2ac gene was not de-
tected in either mouse or cow (Figure 2A). The sequenc-
ing depth for the mouse and cow tissues was lower than
that for the human tissues. If the mouse and cowHist1H2ac
genes were expressed at similar levels to the human ortho-
logue, we would have detected that expression, since the
human HIST2H2AC gene expression was similar to the
HIST2H2AA3 gene whose expression was readily detected
in the mouse and cow samples. We certainly cannot rule out
low levels of expression of the mouse and cow Hist1H2ac
genes. Note that the histone HIST1H3E and HIST1H4H
and HIST2H4 genes are expressed at very low levels in the
human tissues (∼10% of the H2a and H2b genes, Table 1).
The sequencing depth in the cow and mouse tissues was not
sufficient to determine whether or not they were expressed
in these tissues, and only the much deeper TCGA sequenc-
ing data compared to the Illumina data, allowed us to quan-
tify their expression.
The splice site conserved in the human HIST1H2B
genes (Figure 1G) is also conserved in the two cow genes
(Hist1H2bc and Hist1H2bd) and in the mouse Hist1H2bc
gene (Figure 2A). Examination of the sequenced mam-
malian genomes revealed that the 10 nts surrounding
the 5′ splice site in the 3′ UTR in the HIST1H2BC
and HIST1H2BD sequences were highly conserved across
mammalian species (Supplementary Figure S2A and B).
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Figure 2. Polyadenylation of a subset of histone mRNAs is conserved in mouse and cow. (A) Sashimi plots of the expression of the Hist1H2bc gene and
Hist1H2ac gene from the mouse (left) and cow (right) liver. Below are the sequences of the Hist1H2bc 3′ end from four mammals showing conserved
5′ splice sites (green), stem-loop (underlined), HDE (blue) and stop codon (Bold). *’s mark invariant nts. (B) Sashimi plots of the expression of the
Hist2H2aa1 and Hist2H3c gene from the mouse (left) and cow (right) liver. Below is the sequence comparison of the HIST1H2AA3 3′ end showing
conserved polyadenylation signal (red), the stem-loop (underlined) and the HDE (Blue). (C) Sashimi plots of the expression of the HIST1H1C gene from
the mouse (left) and cow (right). Below is the sequence comparison of the HIST1H1C 3′ end. Note that the polyadenylation signal used in human is not
conserved in mouse, cow or dog but the gene is expressed from a poly(A) signal further downstream resulting in a longer 3′UTR (41).
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The sequence of the HIST1H2BK 3′UTR in primates was
similar to the humanHIST1H2BCandHIST1H2BDgenes,
but was totally dissimilar in other mammals (Supplemen-
tary Figure S2C).
The mouse Hist2h2aa1 and cow Hist2H2aa3 genes are
orthologues of the human HIST2H2AA3 gene, and have
a conserved polyadenylation site in the HDE (Figure 2B,
red). This gene is also expressed as a polyadenylatedmRNA
in mouse round spermatids (39). The HIST1H1C gene was
also expressed in tissues from all three species (Figures 1C
and 2C). In humans, the polyA signal is immediately after
the stem-loop, within the HDE (Figures 1C and 2C). How-
ever, in mice the polyA site is more than 1 kB 3′ of the stem-
loop (25,40,41). Thus, the expression of the HIST1H2BC,
HIST1H2BD, HIST2H2AA3 and HIST1H1C genes has
been conserved throughoutmammalian evolution, and they
function in mammals to provide histone mRNAs expressed
in terminally differentiated cells in addition to expressing
non-polyadenylated mRNAs that are cell-cycle regulated in
growing cells.
Validation of polyadenylated histone mRNA expression in
adult mouse liver
To confirm the expression of the mouse histone mRNAs
detected by high-throughput sequencing we analysed his-
tone gene expression in actively growing cultured fibrob-
lasts (NIH3T3 cells) and liver tissue from 72-week-oldmice.
The liver is a relatively homogenous tissue with hepatocytes
making up more than 70% of the cells. In healthy adult liv-
ers, the vast majority of these hepatocytes are quiescent,
only re-entering the cell cycle after injury. Unlike the hu-
man histone genes, the coding regions of the mouse his-
tone genes are highly conserved (>95%) at the nucleotide
level (37). Because of the conserved ORF sequences, we can
use an S1 nucleasemapping assay to simultaneously analyse
both the mRNA expressed from a specific gene, as well as
the mRNAs from all the other histone genes encoding that
histone protein (26,42). A probe labelled in the coding re-
gion will protect all the histone mRNAs to a region close to
the stop codon or initiation codon, as well as a band from
the specific gene extending to the 3′ end or the 5′ end of the
transcript, depending on whether one is probing the 3′ or
the 5′ end of the mRNA (Figure 3A). This highly sensitive
method allows for mapping of multiple isoforms of mRNA
from a single sample. Further, since all of the radioactivity
is at the end of the probe, the relative intensity of the bands
gives the relative amounts of the transcripts. A generalized
schematic is shown in Figure 3A. In each experiment be-
low, the different protected fragments for a given probe are
diagrammed below the autoradiogram.
Total RNA from NIH3T3 cells and mouse liver
was fractionated into polyA− and polyA+ RNA us-
ing oligo-d(T) cellulose. Orthologues of human histone
HIST1H2BC (Hist1H2bc), HIST2H2AA3 (Hist2H2aa1)
and HIST1H4H (Hist1H4h), which were expressed in hu-
man tissues, and the HIST2H3C (Hist2H3c) gene, adjacent
to the Hist2H2AA3 gene, which was not expressed in hu-
man tissues, were analysed by S1 nuclease mapping, using 5
g of total RNA from exponentially growing NIH3T3 cells
and 50g of total liver RNA (Figure 3). In actively prolifer-
ating NIH3T3 cells, most of the 3′ S1 probes map two pro-
tected fragments: one extending to the 3′ end of the mRNA
ending in the stem-loop and a second fragment, mapping
near the stop codon, due to the high level of conservation
between the open reading frames of all mouse histone genes
of a given class (26). This band is indicated by the name of
that class of histone protein (e.g. H3.1 or H2a.1). If the hi-
stone mRNA is spliced or polyadenylated then the probe
is protected up to the point where the mRNA sequence di-
verges from the probe (Figure 3A; e.g. at the 5′ splice site in
Hist1H2bc, before the 3′ end of the mRNA or at the polyA
addition site in Hist2H2aa1).
The S1 nuclease protection assays confirmed the low
levels of histone mRNAs in liver and there were eas-
ily detectable amounts of the polyadenylated forms of
Hist2H2aa1 (Figure 3B, lane 7) and Hist1H2bc (Figure
3C, lane 7) mRNAs. There were no polyadenylated mR-
NAs detected in the NIH3T3 cells. There is some non-
polyadenylated histone mRNA detected in the liver that
gives the same pattern of S1 nuclease protected fragments as
the NIH3T3 cell mRNA. This likely arises from a low level
of expression of the histone mRNAs expressed in growing
cells. Note that the non-polyA mRNA expressed in mouse
liver is greatly reduced compared to NIH3T3 cells, and we
used 10 times more RNA (50 g versus 5 g) for assay
of liver RNA, compared to neonatal mice or growing 3T3
cells.We assayed the sameRNAswith probes forHist1H2ac
(Figure 3D), Hist2H3c (Figure 3F) and Hist1H4h (Figure
3E) genes. There was no polyadenylated mRNAs detected
from these genes in mouse, consistent with the sequencing
data.
Differential transcription of individual histone genes in the
adult mouse liver
Persistent expression of this subset of histone genes might
be due to continued transcription of only these specific
genes following exit from cell cycle. To investigate this possi-
bility, we analysedGRO-Seq data sets performed by Fang et
al. on adult mouse liver (43) and byMin et al. onmouse em-
bryonic stem cells (mESCs) and mouse embryonic fibrob-
lasts (MEFs) (44). In GRO-Seq, the position of RNA poly-
merases capable of elongating already initiated transcripts
is determined. Many genes have RNA polymerase II bound
and paused at the promoter after synthesis of a short (∼50
nt RNA). These RNAs are elongated during the GRO-Seq
experiment as are any RNA polymerases that were elon-
gating transcripts when the nuclei were isolated (45,46). A
major regulatory point in transcription is the transition to
processive transcription when P-TEFb action releases the
stalled RNA polymerase. For genes transcribed at a low
rate, there is a prominent GRO-Seq peak where the poly-
merase pauses, and for genes transcribed at a high rate there
is a smaller peak and transcription throughout the gene
(45,47). There are also genes that have a paused polymerase
which do not express RNA. The level of expression of the
histone genes encoding polyadenylated mRNAs is low in
mouse liver compared to their rate of expression in grow-
ing cells, and one would expect this to be reflected in the
GRO-Seq data.
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Figure 3. Expression of histone mRNAs is mouse fibroblasts cells and mouse liver. (A) Schematic of generalized S1 nuclease protection assay performed on
mouse histone mRNA. A generalized histone mRNA is depicted indicating possible 5′splice sites (5’ss), stem-loop cleavage sites (S-L cleavage) or poly(A)
cleavage sites. S1 nuclease protection probes will protect a given mRNA to the point that cleavage or splicing occurs (indicated below). Note that due to
the high degree of conservation in mice, all of the mRNAs for a specific histone class (i.e. H2B.1 or H2A.2) will be protected up to the stop codon. (B–F)
Total cell RNA from NIH3T3 cells and mouse liver was fractionated into polyA+ and polyA− fractions. Total RNA (whole cell (WC)) and poly(A)+ and
poly(A−) RNA were probed in an S1 nuclease protection assay. Five micrograms of total 3T3 cell RNA and 50 g of liver RNA was analysed using the S1
nuclease protection assay of a 3′ labelled fragment at the indicated restriction enzyme site for (B) Hist2H2aa1, (C) Hist1H2bc, (D) Hist1H2ac, (E) Hist2H3c
or (F) Hist2H4H. The probe used for histone H4H was labelled at the 5′ end of the indicated restriction site. For each experiment, below autoradiogram,
possible mRNA isoforms are indicated as well as protected fragments and sizes for S1 nuclease probes.
In mouse liver, all the histone genes that express
polyadenylatedmRNAs (Table 1) contained sequence reads
corresponding to active transcription (e.g. Hist1H2bc (Fig-
ure 4A) andHist2h2aa1 (Figure 4C)) with prominent peaks
near the start site of transcription, and small amounts of
transcription detected in the gene body, characteristic of rel-
atively lowly expressed genes (46). In contrast, these genes
were highly expressed in actively growing mESC (Figure 4,
lower blue panels) or MEFs (data not shown), with tran-
scribing polymerases detected throughout the gene charac-
teristic of highly active genes, as well as a peak of activ-
ity near the 3′ end where the polymerases would be ter-
minating. In the liver there were genes that were not ac-
tive as detected by GRO-Seq, (e.g. Hist2H3c), while the ad-
jacent gene was transcribed (e.g. Hist1H2aa1, Figure 4C).
The Hist1H2ac gene gave a GRO-Seq signal similar to the
Hist1H2bc gene (Figure 4B), even though mRNA was only
produced from the Hist1H2bc gene. Note that it is not pos-
sible using GRO-Seq to distinguished a gene expressed at
a low level, from a gene that has a stalled polymerase and
does not express mature mRNAs, since in a low expressed
gene, the polymerase is stalled at the promoter most of the
time. Surprisingly, there were many genes that were active
based on the GRO-Seq signal, but for which we did not
detect as accumulating histone mRNAs by RNA-Seq or
the S1 nuclease protection assay, e.g. Hist1H2ac, (Figure
4B) and Hist4H4, Hist1H4h and Hist1H3e (Figure 4D–F).
Overall 80% of the histone genes had an active GRO-Seq
signal at the promoter, while only 20% had no GRO-Seq
signal. Thus, surprisingly the promoters of most of the his-
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Figure 4. Paused polymerases are present on many histone genes in mouse liver. We analysed the GRO-Seq data for mouse liver (43) and from mouse
embryonic stem cells (mESC) and mouse embryo fibroblasts (44)(not shown). The data for selected histone genes are shown in panels A–F for liver (top)
and mESC (bottom). (A) GRO-Seq reads for Hist1H2bc demonstrate a low level of transcription in mature mouse liver and in mESC. In the liver there is a
large peak of paused polymerase and a low level of transcription within the gene. Note that characteristic of the highly expressed genes in the mESC, there
is a large peak at the 3′ end of the gene, but smaller peak at the 5′ end of the gene. (B) GRO-Seq reads at the 5′ end of the Hist1H2ac suggest engagement of
polymerase at the promoter in both liver andmESC.However, Hist1H2acmRNAdoes not accumulate in mouse liver (Table 1). Note that reads throughout
the ORF and 3′UTR of the gene are absent in liver in contrast to mESC where it is actively transcribed. (C) GRO-Seq reads for the Hist2H2aa1 gene shows
a low level of expression in the liver, and a high level of expression in the mESC. In contrast Hist2H3c is not expressed in the liver (there is no paused
polymerase) but shows active transcription in the mESC cells. (D–F) (D) Hist4H4, (E) Hist1H4h and (F) Hist1H3e have a paused polymerase in the liver
and active transcription in the mESC cells.
tone genes in non-dividing tissues were ‘active’ but did not
accumulate RNA. Whether this is due to a lack of process-
ing signals, resulting in rapid degradation of the transcript,
or failure of the polymerase to enter productive elongation
is not clear. Release of paused polymerases is clearly amajor
regulated event on many genes in mammalian cells (45,47).
We verified these findings by analysing RNA Polymerase
II ChIP-Seq data sets performed by Sun et al. on mouse
liver and brain (not shown) (48). These data confirmed data
found by GRO-Seq; however, experimental limitations of
their ChIP-Seq only define a region∼400 nts at which RNA
Pol II was engaged. Therefore, these data were not as pre-
cise, but were consistent with GRO-Seq data.
Differentiation, but not exit from the cell cycle, results in ex-
pression of polyadenylated histone mRNAs
The switch to production of polyadenylated histone mR-
NAs derived from a few genes could result from exiting the
cell cycle, or could be part of the process of terminal differ-
entiation. To distinguish between these two processesmouse
NIH3T3 fibroblasts were arrested either by serum starva-
tion or 3T3-L1 fibroblasts were arrested and induced to ter-
minally differentiate into adipocytes. We arrested NIH3T3
cells by serum starvation (Figure 5A), causing them to enter
a ‘G0’ state. Arrested cells can be stimulated to re-enter the
cell cycle by addition of 10% FBS, and they enter S-phase
12–16 h later. There is a large change in histone mRNA
levels between cells stimulated to enter S-phase and the ar-
rested cells (49). Upon arrest by serum starvation, levels of
Hist1H2bc and other H2B.1 mRNAs were reduced as has
been previously reported (Figure 5B) (49). SLBP protein is
barely detectable (Figure 5C, Lane 1), while SLBP mRNA
is reduced only 4- to 5-fold (Figure 5D), characteristic of
the post-transcriptional regulation of SLBP during the cell
cycle (9). Serum starvation of NIH3T3 cells leads to a 90%
reduction of Hist1H2bc levels as determined by comparing
the intensity of the protected bands from 5 micrograms of
RNA from growing cells with 50 micrograms of RNA from
the arrested cells (see Figure 5E, cf. lanes 2 and 6). There
was no detectable polyadenylated mRNA expressed from
the H2bc gene in the arrested cells (Figure 5E, compared
to the abundant polyadenylated H2bc mRNA in the same
amount of liver mRNA (Figure 5E, lane 1). Note that the
ratio of the other H2b.1 mRNAs (the protected fragment at
the termination codon) and the specific Hist1H2bc mRNA
ending at the stem-loop did not change upon serum starva-
tion. SLBP protein levels rapidly increase as cells re-enter
S-phase (Figure 5D, Lanes 2–6) with the maximum number
of cells in S-phase 16–20 h after serum stimulation. There-
fore, the reduction of SLBP levels is not itself a determinant
for the switch from histone mRNAs ending in a stem-loop
to those ending in a polyA tail.
An alternative possibility is that terminal differentiation,
rather than exiting the cell cycle, triggers the switch from the
utilization of canonical histone 3′ end processing signals to
polyadenylation signals. Kari et al. demonstrated that when
human fibroblasts are differentiated into adipocytes in vitro,
there is polyadenylation of the human HIST1H2BC, D and
K mRNAs and the HIST1H2AC mRNA, although they
did not determine the fraction of these mRNAs that were
polyadenylated (24), or whether there was also polyadeny-
lation of these RNAs in fibroblasts that were arrested but
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Figure 5. Differentiation but not cell cycle arrest activates polyadenylation of histone mRNA. (A) NIH3T3 cells were arrested in G0 by serum starvation
and stimulated to reenter the cell cycle by the addition of 10% FBS as previously described (7). (B) Five micrograms of total cell RNA from the indicated
time points was analysed by S1 nuclease mapping for the Hist1H2bc mRNA. Lane 7 is 12 h after addition of serum and lane 8 is 30 h after addition of
serum. Serum starvation did not result in production of spliced Hist1H2bc mRNA (see also panel E). (C and D) Levels of SLBP protein (panel C) and
mRNA (panel D) were determined in cells serum starved for 6 days (lanes 1) and over 20 h after restimulation with serum (lanes 2–6) by Western blotting
and RNase protection assays, respectively. Levels of SLBP protein reduced >20-fold in cells serum-starved for 6 days, while levels of SLBP mRNA (panel
D) were only reduced 4-fold. The levels of both SLBP protein and SLBP mRNA increased starting 8 h after re-addition of 10% serum. The * (panel C)
indicate cross-reacting proteins whose levels don’t change. (D) The RNase protection assay protects a 276 nt fragment of SLBP mRNA. The markers are
350 nt and 242 nt DNA fragments. (E) S1 nuclease protection assays of Hist1H2bc mRNA in 50 gs of mouse liver RNA (lane 1), 5 or 50 gs of RNA
from growing NIH 3T3 cells (lanes 2,3), 5 gs of RNA from cells starved for 4 days (lane 4) and 5 gs or 50 gs of RNA from cells serum starved for 7
days (lanes 5 and 6). Note that the most abundant H2b mRNA in liver is the polyadenylated H2b mRNA. (E and F) Hist2Haa1 mRNA (panel E) and
Hist1H2bc mRNA (panel F) were analysed by S1 nuclease protection assay in actively growing pre-adipocyte 3T3-L1 cells and differentiated adipocyte
3T3-L1 cells. Lane 1: 5 g 3T3-L1 RNA; Lane 2: 5 g neonatal (P1) mouse RNA; Lane 3, 50 g 14 week liver RNA; Lane 4: 50 g 72 week liver RNA;
Lane 5: 5 g pre-adipocyte RNA; lane 6. 50 g adipocyte RNA. Results demonstrate the production of polyadenylated (E) or spliced and polyadenylated
(F) mRNA after differentiation.
not differentiated. To test whether growth arrest or dif-
ferentiation of the cells led to polyadenylation of histone
mRNA, we compared histone gene expression in serum-
starved 3T3 fibroblasts and 3T3-L1 fibroblasts differen-
tiated into adipocytes (50). Like the NIH3T3 cells, the
pre-adipocyte cells expressed solely stem-loop isoforms of
Hist2H2aa1 and Hist1H2bc (Figure 5F and G, lane 5). Af-
ter seven days of differentiation, the cells had exited the
cell cycle and differentiated into adipocytes as indicated by
the presence of oilRED droplets in the cells (Supplemen-
tary Figure S3A), decrease of expression of Pref-1, and in-
duction of expression of Ppar2 (51)(Supplementary Fig-
ure S3B). There was a large reduction in histone mRNA
levels in the differentiated cell cultures compared to the
pre-adipocytes (Supplementary Figure S3C, cf. lane 1 and
3). We used 10 times more RNA when probing adipocyte
versus pre-adipocytes. As reported by Kari et al. (24), af-
ter differentiation, adipocytes began producing polyadeny-
lated isoforms of these two mRNAs (Figure 5F and G, cf.
lanes 5 and 6). The detection of this band was not due to
the increased loading of mRNA, as we did not detect it in
pre-adipocyte RNA when 50 g was analysed (Supplemen-
tary Figure S3C, lane 2). Less polyadenylated mRNA was
produced compared to the mRNA from the same genes in
mouse liver, and there was still some normally processed
Hist2H2aa1 and Hist1H2bc mRNA produced, likely as a
result of not all cells entering terminal differentiation. Thus,
the process of terminal differentiation may result in alter-
ing the pathway of histone mRNA expression, to activate
expression of H2A and H2B mRNA isoforms that are nor-
mally expressed in terminally differentiated adult tissues.
Adult tissues express specific proteins and mRNAs required
for histone mRNA biosynthesis
There are several genes involved specifically in histone
mRNA metabolism and the expression of these genes has
not been studied in terminally differentiated tissues. They
include SLBP, which binds the stem-loop and is associ-
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ated with histone mRNA in all steps of histone mRNA
metabolism; Lsm10 and Lsm11, proteins found only in the
Sm ring of U7 snRNP (52,53); NPAT, a factor required for
histone gene expression (54–56) that is concentrated in the
Histone Locus Body (HLB), and FLASH, which binds to
the Lsm11 protein and is essential for histone pre-mRNA
processing (57). FLASH is also involved in FAS-casp8 de-
pendent apoptosis, but this may be connected to its role in
the HLB, since an aspect of this process is re-localization
of FLASH from the HLB to the mitochondria (58). Pre-
viously, the Schu¨mperli lab showed that human tissues ex-
pressed SLBP mRNA based on a tissue Northern blot, but
did not determine if SLBP protein was present (59).We con-
firmed that SLBPmRNA is expressed inmouse (Figure 6A)
and in human (Supplementary Figure S4E) liver and brain.
In addition Lsm10, Lsm11, FLASH and NPAT mRNAs
are expressed in both human (Supplementary Figure S4)
and mouse (Supplementary Figure S5) liver and brain, as
well as all the other human tissues in the Illumina BodyMap
Project.
We also quantified the expression data of these factors in
mouse liver and brain and in the TCGA data from human
breast cancer and the adjacent normal tissue (Figure 6B).
Both the normal and tumour tissues expressed the mRNAs
for all the factors involved in histone mRNA biosynthesis.
There were increased levels of SLBP mRNA relative to the
expression of the other factors in the tumour compared to
the normal tissue. Lsm11,NPATandFLASHmRNAswere
also expressed in normal tissue, at a similar level in both
normal and tumour tissue, with the normal tissue slightly
higher. The mRNAs for all the factors were expressed at
higher levels in cultured HeLa cells.
The expression of many proteins, including SLBP, is reg-
ulated post-transcriptionally (9), and the levels of mRNA
do not necessarily reflect the amount of protein present. In
cultured cells, SLBP protein is tightly cell-cycle regulated
by proteolysis and translational regulation, and there are
only small changes in SLBP mRNA level, while U7 snRNP
is present throughout the cell cycle (9). We analysed the
amounts of SLBP protein, U7 snRNA and Lsm11 protein
inmouse liver. SLBPwas readily detected in lysates from ex-
ponentially growingNIH3T3 fibroblasts and from neonatal
(P1) mice (Figure 6C, lanes 1–6). Consistent with SLBP be-
ing present in high levels only in S-phase cells, SLBP was
not detected in the liver lysate by Western analysis, and
was present at very low levels, if at all, in the brain lysate
(long exposure; Figure 6C, lanes 7,8, lower panel). There
was a prominent band detected by the -SLBP antibody in
the liver and in the NIH3T3 lysate which migrated slightly
faster than SLBP (indicated by (*) in Figure 6C) and an-
other band in brain lysate migrating much slower (indicated
by **). However, these cross-reacting bands do not bind
the histone stem-loop in an RNA affinity purification as-
say, while SLBP does (Supplementary Figure S6), indicat-
ing that they are cross-reacting proteins.
We also assayed for both U7 snRNA by Northern blot-
ting (Figure 6D) and the U7 snRNP specific protein,
Lsm11, by Western blotting (Figure 6E), in mouse liver,
brain, NIH3T3 cells and the neonatal (P1) mouse. The lev-
els of U7 snRNA and the U7 core protein Lsm11 in the
P1 mouse were similar to those in NIH3T3 cells, consistent
with many of the cells in the mouse rapidly proliferating.
The amount of U7 snRNA in mouse liver and brain was
lower than the P1 mouse (Figure 6D, lanes 2–4), but, un-
like SLBP, was still readily detectable and Lsm11 was also
detectable at low levels (Figure 6E, lanes 7 and 8). The mR-
NAs for U7 snRNP components Lsm10 and Lsm11 were
also present in adult tissues (Figure 6B; Supplementary Fig-
ures S4 and S5). These results strongly suggest that there is
U7 snRNP present in terminally differentiated cells.
DISCUSSION
Polyadenylation of histone mRNAs allows for expression of
histones outside of S-phase
Following terminal differentiation, it is necessary to replace
histones as they are lost, since the proper ratio of DNA
and histone proteins is critical for genomic stability (60,61).
The average age of many epithelial cells in the human body
is several years with neuronal cells living even longer (62).
In these cells, there must be a mechanism to replace lost
histones that have a half-life of weeks to months (11,12).
In continuously growing cells, there are small amounts
of replication-dependent histone mRNAs expressed in G1
cells (7) and in fibroblasts arrested inG0 there are also small
amounts of histonemRNAprocessed at the stem-loop (Fig-
ure 5B) (49).
In the data from the Illumina BodyMap project, in which
total RNA (ribominus) was sequenced and hence both
polyA+ histone mRNA as well as any normally processed
histone mRNAs were sequenced, we did not detect his-
tone mRNA processed at the stem-loop from histone genes
that are normally actively expressed (e.g. HIST2H3C or
HIST1H1E, Figure 1), although a subset of histone genes
expressed polyadenylated RNAs. In contrast, ENCODE
data from ribominusRNA samples from growing cells there
are large amounts of replication dependent histonemRNAs
expressed and very small amounts of polyadenylated his-
tone mRNAs were expressed (33,63).
A variety of mechanisms might be utilized for synthesis
of different histone proteins in terminally differentiated tis-
sues. One obvious mechanism to provide replacement hi-
stone is to utilize different genes to encode the replace-
ment histones. This is the case for the histone H3 genes, but
not the other core histone genes. Previously, H3.3 (H3F3A,
H3F3B) had been identified as a replacement histone that
accumulates as a large fraction of the histone H3 in non-
dividing cells over an extended period of time (months to
years) (64), as well as playing important functions in gene
regulation in growing cells. The H3.3 protein is expressed
from genes that produce a spliced polyadenylated mRNA
that is not linked to the replication dependent histone gene
clusters (65,66). Histone H1O has been suggested to func-
tion as a replacement histone for H1 proteins, and again,
this gene is expressed as a polyadenylated mRNA lacking a
stem-loop and is not linked with the replication-dependent
histone gene cluster (67,68).
For the other 3 classes of core histone genes, there are
no obvious replacement histone genes, although there are
variant proteins for histone H2A. All of the polyadenylated
H2A variants (H2A.X, H2A.Z, macroH2A) have distinct
functions. NoH2B orH4 genes have been identified outside
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Figure 6. Expression of Histone Specific factors in mammalian tissues. (A) Sashimi plot demonstrating continued expression of SLBP mRNA in mouse
brain (top) and liver (bottom) from (31) (B) RNA-Seq data from 3 replicates of mouse liver and mouse brain (31) and 4 sets of paired human normal breast
and breast tumour tissue were analysed for levels of expression of Lsm11, NPAT, SLBP and FLASH. For the 4 human and 3 mouse samples, the average
plus standard deviation is indicated. Note the expression levels of all the factors except SLBP were slightly higher in normal tissue. The expression levels
of SLBP were higher in the tumour tissue (P = 0.06) in a Student’s t-test. (C) Analysis of SLBP by Western blotting in cells and tissues from neonatal (P1)
mouse (lanes 1–3), 3T3 cells (lanes 4–6) and mouse liver (lane 7) and brain (Lane 8). The amount of protein loaded is indicated above each lane. Tissue
specific cross-reacting bands are indicated (*, liver and **, brain) (D) Analysis of U7 snRNA levels in cells and tissues. Twenty five micrograms of total
cell RNA from 3T3 cells, a neonatal (P1) mouse, liver and brain were resolved on a 15% urea-polyacrylamide gel and transferred to a nylon membrane.
Membranes were probed for U7 snRNA and visualized by exposure to phosphor screen. The gel was stained with ethidium bromide and photographed
to determine the relative amounts 5S rRNA. (E) Analysis for Lsm11 by Western blotting in cells and tissues. The indicated amounts of the same extracts
used in panel C are shown. Note the high levels of Lsm11 in the P1 mouse (arrow) consistent with the high amount of U7 snRNA in the P1 mouse.
of those in the replication-dependent clusters. We propose
that the small subset of the replication-dependent genes
that are expressed as polyadenylated mRNAs in termi-
nally differentiated cells encode the replacement H2A, H2B
and H4 histone proteins. We found both RD-histone H2A
and RD-histone H2B genes expressed in all tissues. Most
of these mRNAs contain both a stem-loop and a polyA
tail, similar to the H2A.X mRNA expressed outside of S-
phase. The exceptions are the HIST1H2BC, HIST1H2BD
andHIST1H2BKmRNAs, in humans, and Hist1H2bc and
Hist1H2bd mRNAs in other mammals. These spliced H2B
mRNAs have a conserved structure, using a 5′ donor site
before the stem-loop, resulting in an mRNA that does not
contain the stem-loop and is not a target for nonsense
mediated decay. The 3′ UTR and 5′ splice site are con-
served among all these H2B genes, even though they encode
slightly different proteins. The other expressed human H2B
gene, HIST2H2BE, is found in the HIST2 cluster, and this
gene encodes a polyadenylated mRNA that still contains
the stem-loop, similar to HIST1H1C or HIST2H2AA3.
Recently, it has been shown that over a six-month period
in mouse brain, that histone H3.1, H3.2 and H4 are signif-
icantly more stable than histone H2A and H2B (12). This
observation suggests that the H2A-H2B protein dimer has
a shorter half-life than the H3-H4 tetramer (12). Therefore,
H2A and H2B genes would need to be expressed at higher
levels to compensate for the increased turnover. There is an
isolated RD-H4 gene on human chromosome 11, but this
HIST4H4 gene although conserved as an isolated gene in
mammals, is expressed only as a stem-loopRNA (32), and is
not expressed in non-dividing tissues.We identified two pos-
sible replacement histoneH4 genes, which were expressed at
very low levels (∼5- to 10-fold less than the H2A and H2B
genes), in all human tissues we analysed. Since there have
been no other histone H4 genes or cDNAs identified other
than the RD-histone H4 genes, these two genes likely pro-
vide the replacement histone H4 protein. The depth of se-
quencing in the cow and mouse samples was not sufficient
to detect a similar level of expression from the H4 genes in
these species.
Histone H3.3 has long been recognized as a replace-
ment histone, which replaces most of the histone H3 in ter-
minally differentiated cells. However, a significant amount
of the H3.2 protein remains in non-dividing cells in the
mouse (14) (see Figure 7). We identified one RD-histone
H3 gene, HIST1H3E, which is expressed at low levels in
terminally differentiated human cells, similar to the level of
the HIST1H4H gene. This is consistent with the possibil-
ity that there is a small amount of ‘replacement’ histone H3
encoded by this replication-dependent gene.
The pattern of histone protein changes that occur in
mouse liver as a function of age was determined byA. Zwei-
dler (14) over 30 years ago, and a figure showing the changes
in liver histones from birth to 30 weeks of age is repro-
duced in Figure 7. There are changes in the subtypes of 3
core histones, H2A, H2B and H3, encoded by RD-histone
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Figure 7. Expression of Histone proteins in mouse liver. Total histones
were isolated from purified nuclei were prepared from the livers of mice
from 1 week before birth (−1) to 30 weeks of age. The histones were re-
solved on Triton-X/Acid/Urea Polyacrylamide gels (6 mM Triton-X 100,
5% Acetic Acid, 6M Urea) and stained with Amido Black. ‘T’ is histones
from mouse thymus that shows a similar pattern as mouse embryos. The
H2A.1, H2B.2 and H3.1 and H3.2 proteins decrease over time, while the
H2A.2, H2B.1, H3.3 and H10 proteins accumulate with time. The mul-
tiple bands for H3.2, H3.3 and H4 proteins are acetylated forms of his-
tones. These changes in protein levels are consistent with the core histone
genes that continue to be expressed in tissues. Reproduced from Zweidler,
A. (1984) In: Stein, G., Stein, W. and Marzluff, W. F. (eds.),Histone genes:
structure, organization and regulation. JohnWiley and Sons, NewYork, pp.
373–395 with permission of John Wiley & Sons Ltd. Copyright C© 1984 by
John Wiley & Sons, Inc.
genes (all the histone H4 genes encode the same protein).
There are increases in the relative amounts of the H2A.2
protein (encoded by the Hist2H2aa1 gene), the H2B.1 pro-
tein (encoded by the Hist1H2bc gene), and the H3.2 pro-
tein, (encoded by the Hist1H3h gene) in mouse liver dur-
ing the first 30 weeks. At the same time the H3.3 and H1O
proteins increase. Thus, the RD-histone genes we have iden-
tified encode the proteins that accumulate in adult mouse
non-dividing tissues.
Polyadenylation of histone mRNAs may be a feature of ter-
minal differentiation
Knockdown of a number of factors in RNAbiosynthesis by
RNAi in cultured human cells leads to polyadenylation of a
small percentage of histone mRNA. These include knock-
down of NELF, a transcription elongation inhibitor (19);
ARS2, a factor required for efficient cell cycle progression
(20) that is also present in the NEXT complex that binds
to nascent capped transcripts (69); CDK9 (21), a transcrip-
tion elongation factor; and RNF20 and RNF40, which are
involved in H2B ubiquitination (21). In many of these ex-
periments the primary assay is measurement of changes of
polyadenylated histone mRNA by qRT-PCR of oligo(dT)
primed cDNA. Results are often reported as ‘fold-increase’
and large fold-increases in polyadenylated histone mRNAs
are often observed using this technique. In the cases where
the expression of the polyadenylated histone mRNAs rela-
tive to normally processed histone mRNAs have been mea-
sured (19,20,22), the amount of poly(A)+ histone mRNA is
in the range of 2–3% of the properly processed RNA. The
large increases reported reflect the fact that the amount of
polyadenylated histone mRNA under normal conditions is
extremely low. It is likely that all of these treatments disrupt
the coupling between transcription and histone 3′ end pro-
cessing, resulting in a small amount of RNA, which is not
processed normally and may then be polyadenylated. The
HIST2H2AA3 mRNA and several histone H2B mRNAs
which are expressed in tissues are among those affected. In
at least one case, the polyadenylated histonemRNA formed
is not the same as the polyadenylated histone mRNAs ex-
pressed in tissues. Knockdown of SLBP resulted in expres-
sion of a novel histone H4 mRNA detected by Northern
blotting (23). This RNA was derived from the HIST1H4J
gene, which is not expressed in human tissues.
The switch in histone gene expression is likely a conse-
quence of terminal differentiation, and not simply a con-
sequence of cells stopping cell division. When 3T3 fibrob-
lasts are arrested cells in G0 by serum starvation, we do
not detect expression of polyadenylated histone mRNAs
over the 7 day serum starvation. When we differentiated
the mouse 3T3-L1 fibroblasts over 7 days, polyadenylated
Hist1h2bc and Hist2h2aa1 mRNAs were expressed, consis-
tent with activation of this pathway in terminally differen-
tiated cells, and not simply as a result of serum starvation.
Our data contrasts with the report of Pirngruber et al. that
serum starvation of HTC116 cells resulted in polyadenyla-
tion of HIST1H2BC mRNA (70), and other pharmacolog-
ical treatments that also arrest cells show a similar result.
In their study, they reported a 3-fold increase in polyadeny-
latedHIST1H2BC in response to serum starvation, but they
did not measure the absolute amount of polyadenylated
mRNAs expressed. In subsequent experiments, Kari et al.
(24) reported that there are increases in the same polyadeny-
latedH2B andH2AmRNAs thatwe observed are expressed
in human tissues, when human fibroblasts differentiate into
adipocytes in vitro. They did not compare these results with
the effect of serum starving these fibroblasts.
Rai et al. have identified some histone genes that are ex-
pressed as polyadenylated mRNAs in response to DNA
damage or senescence (71). In their study, they propose the
concept of ‘chromostasis,’ through which DNA replication
independent chromatin regulators maintain dynamic chro-
matin in senescent cells in culture. They demonstrate that
HIRA is required for efficient deposition of histones dur-
ing senescence. Importantly, using affymetrix microarrays,
they identify some of the genes identified in this study as ex-
pressed (HIST1H2AC, HIST1H2BC and HIST1H2BK) in
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senescent cells, which may represent another type of termi-
nal differentiation.
How does the switch to polyadenylated histone mRNAs oc-
cur?
A combination of factors likely determines how his-
tone mRNAs switch their 3′ end formation and which
genes remain expressed. In actively growing cells, at the
G1/S-phase transition, CycE/Cdk2 phosphorylates NPAT
(54,55,72,73) resulting in a high rate of expression of pro-
cessed histone mRNAs. In cultured mammalian cells, there
is a significant rate of histone gene transcription outside of
S-phase (49) or when histone RNA levels are rapidly re-
duced by inhibiting DNA replication (74,75). Surprisingly,
the available GRO-Seq data from Fang et al. (43) show that
in mouse liver most histone genes (about 80%) have stalled
RNA polymerase II at their promoters including the genes
that express polyadenylated histonemRNAs.Many of these
genes do not express histone mRNA in tissues.
One could imagine two different extremes for the state of
these genes. First, only the genes expressed in tissues release
RNA polymerases at a low rate from their promoters into
productive elongation or second, many of the RD-histone
genes with stalled polymerases at their promoters are tran-
scribed at a low level but do not accumulate any mRNA
because there are not effective splicing/polyadenylation sig-
nals. Comparing theGRO-Seq data from growing cells with
mouse liver and brain, it is clear that a major regulatory
step is at the level of transition of the RNA polymerase
into processive elongation after synthesis of the short tran-
script. Genes that are expressed as polyadenylated mRNAs
also have a stalled polymerase at their promoter, and the re-
lease of this polymerase into productive elongation is likely
tightly controlled resulting in production of low levels of
polyA mRNA. The importance of regulation at this step
has been emphasized recently by studies of Adelman et al.
(47,76). The levels of some of these mRNAs (HIST1H3E,
HIST2H4, HIST1H4H and HIST1H2AC) may be further
reduced byNMD, since they are all spliced with an intron in
the 3′ UTRmore than 100 nts 3′ of the stop codon. Both the
HIST1H2B mRNAs, and the HIST2H2AA3 mRNAs that
are expressed are not sensitive to NMD and accumulate at
significantly higher levels that the other transcripts that are
spliced.
Some of the histone genes, e.g. the Hist2H3c gene adja-
cent to the expressed Hist2H2aa1 gene, are not expressed in
tissues (do not have a stalled polymerase at the promoter),
although the Hist2H3c gene is expressed at high levels in
cultured mouse cells (75). In growing cultured cells, the his-
tone genes do not show a strong GRO-Seq peak at the pro-
moter, but show transcription throughout the gene with a
major peak 3′ of the processing site, consistent with the high
level of RNA polymerase present at histone genes (77,78).
The expression of components of the histone locus body,
NPAT and FLASH, in terminally differentiated cells sug-
gest that they play a role in the expression of histone genes
in tissues, supporting a basal level of transcription of the
histone genes, likely by forming a histone locus body. In
normally growing fibroblasts (54,56) and ES cells (79,80),
the HLB persists throughout the cell cycle, as it does in
Drosophila, both in replicating and non-replicating cells
(81–83). SLBP mRNA was also expressed in the tissues. It
was expressed at higher levels in cultured cells compared to
the other mRNAs, and at higher levels in human breast tu-
mours relative to the adjacent normal tissue. In contrast to
the components of U7 snRNP, the level of SLBP protein in
the liver and brain is dramatically reduced despite expres-
sion of the SLBP mRNA, as it is in cultured cells in G1.
The reduction of SLBP protein is unlikely to be the deter-
minant for the switch to polyadenylated histone mRNA in
differentiated cells. This is most clearly demonstrated by ar-
rest of fibroblasts in a G0 state, which reduces the levels of
SLBP protein, but does not cause result in the accumula-
tion of polyadenylated histone mRNA, and the failure of
the HIST1H4J gene to be expressed in tissues, although it
is expressed as a polyadenylated mRNA in HeLa cells when
SLBP is knocked down (23).
In summary, we report a subset of histone genes express
polyadenylated histone mRNAs (many of which are also
spliced) in terminally differentiated tissues. These mRNAs
likely encode the replacement core histones which turn over
very slowly in these cells, which are very long-lived. The pro-
teins expressed from these genes encode the same histone
variants proteins shown to accumulate in mouse tissues by
Fred Zweidler years ago, replacing some of the histone pro-
teins originally present in these tissues.
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